Canada House Enters into Agreement with Pure Extracts to Distribute Concentrate Products

Published: February 19, 2021

Canada House Enters into Agreement with Pure Extracts to Distribute Concentrate Products

Canada House Wellness Group, a fully integrated medical cannabis company, announced that it has entered into a Cannabis 2.0 distribution agreement with Pure Extracts Technologies Corp., a plant-based extraction company, focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector. Under the terms of the Agreement, the Company’s wholly owned subsidiary, Abba Medix Corp., will distribute Pure Extracts’ line of concentrate products through its established provincial distribution channels.

“We’ve been extremely impressed with the Pure Extracts team and the brand presence they have established particularly in the western provinces,” commented Chris Churchill-Smith, Canada House CEO.  “We look forward to supporting their commercialization efforts in a mutually beneficial way.”

Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Please visit

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Find out more at